|
1.
|
原著(症例報告除く)
|
Cone-Beam CT to CT Image Translation Using a Transformer-Based Deep Learning Model for Prostate Cancer Adaptive Radiotherapy 2025/08
|
|
2.
|
原著(症例報告除く)
|
Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction 2025/08
|
|
3.
|
原著(症例報告除く)
|
Visualization and evaluation of the quality variations of EBT4 Gafchromic film using multidimensional scaling and Lie derivative image analysis. 2025/06
|
|
4.
|
原著(症例報告除く)
|
Efficacy of Molecular-targeted Agents in Vertebral Metastasis Management in Non-small Cell Lung Cancer 2025/03
|
|
5.
|
原著(症例報告除く)
|
Image-guided high-dose-rate interstitial brachytherapy with custom-made surface applicators for lower lip cancer as monotherapy. Technique, long-term clinical results, and quantitative dose-volume evaluation: A case series 2025/02
|
|
6.
|
原著(症例報告除く)
|
Combined external radiotherapy and single-fraction palliative high-dose-rate interstitial brachytherapy for a patient with a base of tongue cancer who had a previous radiation history 2025/01
|
|
7.
|
原著(症例報告除く)
|
Diffusion equation quantification: selective enhancement algorithm for bone metastasis lesions in CT images 2024/12
|
|
8.
|
症例報告
|
Single-Fraction Palliative High-Dose-Rate Brachytherapy for Symptom Management in a 97-Year-Old Patient With Dementia 2024/08
|
|
9.
|
原著(症例報告除く)
|
Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes 2024/06
|
|
10.
|
原著(症例報告除く)
|
Hands-on-training tailored in response to pre-questionnaire-based survey on image-guided brachytherapy effectively reduces anxiety about its implementation 2024/05
|
|
11.
|
原著(症例報告除く)
|
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy 2024/04
|
|
12.
|
その他
|
In Regard to Kodaira et al 2024/03
|
|
13.
|
原著(症例報告除く)
|
Patterns of care for brachytherapy in Japan 2024/03
|
|
14.
|
その他
|
Accelerated Fractionation for Glottic Cancer 2024/02
|
|
15.
|
原著(症例報告除く)
|
The Dosimetric Analysis of Duodenal and Intestinal Toxicity After a Curative Dose Re-irradiation Using the Intensity-Modulated Radiotherapy for Abdominopelvic Lymph Node Lesions 2023/12
|
|
16.
|
原著(症例報告除く)
|
KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer 2023/07
|
|
17.
|
原著(症例報告除く)
|
Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy , intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy 2023/06
|
|
18.
|
原著(症例報告除く)
|
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer 2023/05
|
|
19.
|
原著(症例報告除く)
|
HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution 2023/02
|
|
20.
|
原著(症例報告除く)
|
Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study 2023/02
|
|
21.
|
原著(症例報告除く)
|
The combination of volumetric arc radiation therapy and boost high-dose rate interstitial brachytherapy for T3N2c tongue cancer: a technical report 2023/01
|
|
22.
|
原著(症例報告除く)
|
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial 2022/08
|
|
23.
|
原著(症例報告除く)
|
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 months 2022/07
|
|
24.
|
原著(症例報告除く)
|
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10 2022/06
|
|
25.
|
原著(症例報告除く)
|
Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers 2022/05
|
|
26.
|
原著(症例報告除く)
|
Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer 2022/03
|
|
27.
|
原著(症例報告除く)
|
Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies 2022/02
|
|
28.
|
原著(症例報告除く)
|
Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer? 2022/02
|
|
29.
|
原著(症例報告除く)
|
Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity 2022/02
|
|
30.
|
原著(症例報告除く)
|
Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary Glands 2022/02
|
|
31.
|
原著(症例報告除く)
|
Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancer 2022/01
|
|
32.
|
原著(症例報告除く)
|
Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study. 2022
|
|
33.
|
原著(症例報告除く)
|
Reirradiation for Nasal Cavity or Paranasal Sinus Tumor-A Multi-Institutional Study. 2021/12
|
|
34.
|
原著(症例報告除く)
|
Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer 2021/12
|
|
35.
|
原著(症例報告除く)
|
New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer. 2021/11
|
|
36.
|
原著(症例報告除く)
|
Gel spacer to protect carotid artery and reconstructed jejunum in image-guided interstitial brachytherapy for recurrent hypopharyngeal cancer: a technical report. 2021/10
|
|
37.
|
原著(症例報告除く)
|
Fractionation or tumor factors-what matters in carotid blowout syndrome? 2021/08
|
|
38.
|
原著(症例報告除く)
|
Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors 2021/07
|
|
39.
|
その他
|
Posterior Margins in Prostate Cancer Radiation Therapy 2021/04
|
|
40.
|
原著(症例報告除く)
|
Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy 2021/04
|
|
41.
|
原著(症例報告除く)
|
A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan 2021/03
|
|
42.
|
原著(症例報告除く)
|
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer 2021/03
|
|
43.
|
原著(症例報告除く)
|
A national surveillance study of the current status of reirradiation using brachytherapy in Japan 2021/02
|
|
44.
|
原著(症例報告除く)
|
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter study. 2021/01
|
|
45.
|
症例報告
|
High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report 2020/12
|
|
46.
|
その他
|
Objective and quantitative assessment in acute radiation-induced skin toxicity: Way to overcome the barriers? 2020/10
|
|
47.
|
原著(症例報告除く)
|
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer - Brachytherapy enhanced late GU toxicity especially in elderly 2020/10
|
|
48.
|
原著(症例報告除く)
|
Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx. 2020/08
|
|
49.
|
原著(症例報告除く)
|
Is there clinical meaningful threshold in dose volume analysis between grade 0-2 and 3-4 radiation dermatitis? 2020/08
|
|
50.
|
原著(症例報告除く)
|
A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with "intentional internal high-dose policy" high-dose-rate interstitial brachytherapy. 2020/07
|
|
51.
|
原著(症例報告除く)
|
Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy-A Confirmation Study 2020/07
|
|
52.
|
原著(症例報告除く)
|
Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer 2020/06
|
|
53.
|
原著(症例報告除く)
|
High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer. 2020/05
|
|
54.
|
原著(症例報告除く)
|
子宮頸癌に対するＣＴを用いたImage-guided brachytherapy（IGBT）におけるHigh-risk CTV（CTVHR）に関する多施設共同研究 Multi-center study on consensus of high risk CTV in image-guided brachytherapy for cervical cancer 2017/09
|
|
5件表示
|
|
全件表示(54件)
|
